Drug reference

capmatinib

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 229

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(kap-ma′ti-nib) Tabrecta

PDF page 229

Functional class

Func. class.: Antineoplastic

PDF page 229

Uses

USES: Treatment of metastatic non– small-cell lung cancer with a mutation of mesenchymal-epithelial transition (MET) exon 14 skipping

PDF page 229

Safety

Contraindications

CONTRAINDICATIONS: Hyper- sensitivity, pregnancy, breastfeeding

PDF page 229

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: PO 400 mg bid, continue until disease progression or unacceptable tox- icity

PDF page 229

Available forms

Available forms: Tablet 150, 250 mg

PDF page 229

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

capmatinib

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 229

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(kap-ma′ti-nib) Tabrecta

PDF page 229

Functional class

Func. class.: Antineoplastic

PDF page 229

Uses

USES: Treatment of metastatic non– small-cell lung cancer with a mutation of mesenchymal-epithelial transition (MET) exon 14 skipping

PDF page 229

Safety

Contraindications

CONTRAINDICATIONS: Hyper- sensitivity, pregnancy, breastfeeding

PDF page 229

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: PO 400 mg bid, continue until disease progression or unacceptable tox- icity

PDF page 229

Available forms

Available forms: Tablet 150, 250 mg

PDF page 229

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.